FolioLanternBeta
AMGNAmgen

James Bradner

EVP, Research and Development at Amgen, as of May 11, 2026No sales or purchases in the past 12 months.

Updated Oct 15, 2026 from SEC filings · covers Oct 16, 2025 to Oct 15, 2026
1
company filed for

Shares held at Amgen is not shown: the holdings do not reconcile with the filings. Why

Last filing: May 11, 2026.

Pattern

What the filings show, past 12 months. Nothing here rates or predicts.

Roles from filings

Every company we track where this person has filed, newest filing first.

CompanyTitleFirst filingLatest filing
Amgen (AMGN)EVP, Research and DevelopmentFeb 12, 2024May 11, 2026

Recent filings

The last 4 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.

This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.